Spenda (ASX:SPX) has agreed to sell its invoice financing portfolio to Grapple for $2 million, subject to portfolio ...

The University of Queensland (UQ) and INOVIQ Ltd (ASX: IIQ) have joined forces to develop a groundbreaking blood test for ...

Savannah Goldfields Limited (ASX:SVG) has successfully completed its fully underwritten capital raising programme totalling ...

Aerometrex Limited (ASX:AMX) has commenced a strategic review of its business, led by Acting CEO Rob Veitch and supported by ...

Australian gold miner Auric Mining (ASX:AWJ) has reached a major milestone at its Jeffreys Find Gold Mine, with total gold ...

McPherson’s Limited (ASX:MCP) has begun its transition to a new operating model following a comprehensive review of its route ...

AustralianSuper, the country’s largest industry superannuation fund, has been fined $27 million by the Federal Court for ...

US Markets US stocks tumbled on Friday amid fresh economic data that heightened fears of a slowing economy and stubborn ...

Westpac has partnered with Accenture to create advanced AI agents—referred to as agentic AI—that do more than just relay ...

China continues to play a significant role in the rare earth market, yet the global landscape is undergoing notable changes.

In the first episode of a six-part interview series on immunotherapy, Mark Folke, CEO and Executive Director of Immutep (ASX:IMM), discusses the significance and rapid growth of immuno-oncology.

Mayfield Childcare Limited (ASX:MFD) has appointed Daniel Stone as its new Chief Executive Officer, effective April 8, 2025. Stone will replace outgoing CEO Ashok Naveinthiran, who retires on March 10 ...